Drastic healing process after pembrolizumab monotherapy in a case of advanced squamous cell carcinoma with severe bronchial stenosis observed over a two‐year period using continuous bronchoscopy: A case report-Reference-Cited by-同舟云学术

Drastic healing process after pembrolizumab monotherapy in a case of advanced squamous cell carcinoma with severe bronchial stenosis observed over a two‐year period using continuous bronchoscopy: A case report

Published:2020-03-06 Issue:5 Volume:11 Page:1339-1343
ISSN:1759-7706
Container-title:Thoracic Cancer
language:en
Short-container-title:Thorac Cancer

Author:

Morikawa Kei¹^ORCID,Kida Hirotaka¹,Handa Hiroshi¹,Inoue Takeo¹,Miyazawa Teruomi¹,Mineshita Masamichi¹

Affiliation:

1. Division of Respiratory Diseases, Department of Internal MedicineSt. Marianna University School of Medicine Kawasaki Japan

Publisher

Wiley

Subject

Pulmonary and Respiratory Medicine,Oncology,General Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1759-7714.13390

Reference14 articles.

1. Pembrolizumab for the Treatment of Non–Small-Cell Lung Cancer

2. Nivolumab versus Docetaxel in Advanced Nonsquamous Non–Small-Cell Lung Cancer

3. Nivolumab versus Docetaxel in Advanced Squamous-Cell Non–Small-Cell Lung Cancer

4. Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer

5. Pembrolizumab versus docetaxel for previously treated, PD-L1-positive, advanced non-small-cell lung cancer (KEYNOTE-010): a randomised controlled trial

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pseudoprogression in lung cancer patients treated with immunotherapy;Critical Reviews in Oncology/Hematology;2022-01

2. Immune Checkpoint Inhibitor-Associated Pneumonitis in Non-Small Cell Lung Cancer: Current Understanding in Characteristics, Diagnosis, and Management;Frontiers in Immunology;2021-05-28

3. Complete response of squamous cell carcinoma of the lung following treatment with pembrolizumab in an elderly patient: A case report;Thoracic Cancer;2020-11-10